Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Journal of Crohn'S & Colitis|February 14, 2026
Cutaneous autoimmune blistering disease during mirikizumab therapy in a patient with ulcerative colitis: a new potential trigger?Lucia Centanni, Fabrizio Fanizzi, Ferdinando D'amico, et al.Current Opinion in Pharmacology|October 22, 2025
Targeting the unmet needs in IBD: Emerging therapies beyond biologics and small moleculesFabrizio Fanizzi, Laurent Peyrin-Biroulet, Silvio Danese, et al.Current Opinion in Pharmacology|October 23, 2025
Revolutionizing UC monitoring: The emerging role of intestinal ultrasoundFabrizio Fanizzi, Alessandra Zilli, Ferdinando D'Amico, et al.Best Practice & Research. Clinical Gastroenterology|August 6, 2025
Treatment targets in IBD: is it time for new strategies?Fabrizio Fanizzi, Ferdinando D'Amico, Laurent Peyrin-Biroulet, et al.Cancers|January 25, 2025
Venous Thromboembolism in Patients with Neuroendocrine Neoplasms: A Systematic Review of Incidence, Types, and Clinical OutcomesSara Massironi, Lorenzo Gervaso, Fabrizio Fanizzi, et al.Expert Review of Clinical Immunology|April 22, 2026
Inflammatory bowel disease and Primary sclerosing cholangitis: immunological links and clinical outlookSara Massironi, Fabrizio Fanizzi, Federica Invernizzi, et al.Therapeutic Advances in Gastroenterology|November 27, 2024
Raising the bar in ulcerative colitis managementFabrizio Fanizzi, Mariangela Allocca, Gionata Fiorino, et al.Microorganisms|January 25, 2025
Role of Probiotics in the Management of Patients with Ulcerative Colitis and PouchitisFrancesca Bernardi, Fabrizio Fanizzi, Tommaso Lorenzo Parigi, et al.Pharmaceuticals (Basel, Switzerland)|January 25, 2025
Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine ApproachesLucia Centanni, Clelia Cicerone, Fabrizio Fanizzi, et al.Microorganisms|September 28, 2024
The Role of Fecal Microbiota Transplantation in IBDFabrizio Fanizzi, Ferdinando D'Amico, Isadora Zanotelli Bombassaro, et al.Pageof 2